使SSRI

Amir Human Hoveidaei1, Amirhossein Ghaseminejad-Raeini2, Mohammad Sadegh Fallahi2

  • 1International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Schoeneman Building, 2 Floor, 2401 West Belvedere Avenue, Baltimore, MD, 21215, USA.

概括

选择性血清素再吸收抑制剂 (SSRI) 在部手术患者中增加了术后输血的风险. 这一发现特别适用于像定针,ORIF和THA这样的程序,突显了需要仔细的患者管理.